ABSTRACT
Objective To investigate the influencing factors on re-examination compliance of patients with breast cancer Who were in the stage of recovery.Methods By clinic services and telephones,we investigated the reexamination compliance of 189 cases of breast cancer.Results 66.1% of the cases took periodic re-examinations and on the opposite,33.9% of the patients didn't do so.Statistical meaning could be found from the difference of ages,living sites and survival time limits(P＜0.05).Conclusions The main factors to influence the re-examination compliance of patients with breast cancer are age,living site and survival time limit.And it is possible to improve the re-examination compliance of patients by enhancing health education,raising medicsl levels and service qualities,and creating comfortable environment for patients.
ABSTRACT
Objective To compare the efficacy and side effect of radiotherapy and radiotherapy combined with chemotherapy for esophageal carcinoma. Methods 90 patients with esophageal carcinoma were randomly divided into tow groups: control group 45 patients and combined therapy group 45 patients. Radiotherapy was performed on the control group, radiotherapy combined with chemotherapy which consisted of Carboplatin, 5-Fluorouracil and Hydroxycamptothecine were carried out the combined group. The two groups were under the same technical conditions and radiation dose. Three radiation fields were performed on both two groups at 200 cGy each time. The total radiation dose were 6 400 ~ 6 800 cGy. Results The local tumor control rate of combined group were higher than control group markedly. The acute gastrointestinal tract reaction and myetlosuppression were more serious than the control group. However, the late radiation reaction were not significance between the two groups. The main late reaction were radiation esophageal stricture and lung fibrosis. Conclusion Radiotherapy combined with chemotherapy is able to enhance the local control rate, 1 year and 3 years survival rate for esophageal carcinoma, but the acute side effect also increased and the late reaction were not increased.
ABSTRACT
Objective To analyze the efficacy and debase the toxicity of radiotherapy combined with composite Kushen injection in treatment of esophageal carcinoma patients. Methods A total of 126 cases of esophageal cancer were treated by radiotherapy were analysed. All patients were treated with the continuative hyperfractionated radiotherapy. The total dose was 66 ~ 74 Gy/5 ~ 7 wk, 2.2 ~ 2.4 Gy/d of esophageal carcinoma patients. Two groups were given respectively delivered with the same radioactive dosages and methods.But the synthetic group was treated by radiotherapy with composite Kushen injection. composite Kushen injection was given at the dosage of 20 ml with 500 ml of saline infusion for 20 consecutive days. Results X-ray grades of esophageal cancer after radiotherapy. The grade I of X-ray manifestation after radiotherapy for patients in synthetic group was superior to that patient in the radiotherapy alone group. (60.4 % vs 41 %; ?2 =4.57, P